☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
sage therapeutics
Sage Therapeutics Provides Data from the P-II (LIGHTWAVE) Trial of Dalzanemdor to Treat Mild Cognitive Impairment and Dementia in...
October 8, 2024
Sage and Biogen Initiate Rolling Submission of NDA to US FDA for Zuranolone to Treat Major Depressive Disorder
May 2, 2022
PharmaShots Weekly Snapshot (December 02-06, 2019)
December 9, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
